Empowering Scientific Breakthroughs: How Scientists Can Use AI and ML for Drug Discovery

Life Sciences, Pharmaceutical, Drug Discovery & Development,
  • Tuesday, October 29, 2024 | 11am EDT (NA) / 3pm GMT (UK) / 4pm CET (EU-Central)
  • 60 min

In the rapidly evolving field of drug discovery, artificial intelligence (AI) and machine learning (ML) have become well-known multipliers in accelerating research and enhancing the development of therapeutic compounds.

This talk will explore Revvity Signals’ strategic journey and share details of existing AI/ML integrations into current Revvity Signals’ software solutions. The team will also discuss the future picture and direction of travel for AI/ML and their software solutions. The speakers will share their future direction and pipeline and explore how these solutions will continue to empower Scientists to drive significant breakthroughs in drug discovery.

They will share their insights into the opportunities afforded by AI/ML. Specifically, they will provide examples of how these tools are currently assisting researchers in their daily work in two ways: 1) to help Scientists document or efficiently use the software and 2) to help scientists accelerate their science.

They will also discuss about augmented intelligence, where AI and ML tools complement and enhance human expertise rather than replace it. The goal of augmented intelligence is to create solutions that support decision-making processes and accelerate routine tasks, allowing researchers to dedicate more time to higher-level analysis and creative problem-solving.

Register for this webinar today to discover how cutting-edge AI and ML technologies are being leveraged for drug discovery and development.

Speakers

Zev Wisotsky, Revvity Signals

Zev Wisotsky, Director of Drug Discovery Informatics, Revvity Signals

Zev Wisotsky is Director of Drug Discovery Informatics at Revvity Signals. His scientific training and research background includes neuroscience, biochemistry, molecular biology and drug discovery. He has spent more than eight years in software in go-to-market teams across industries with a heavy focus on biopharma/biotech R&D. 

Message Presenter
David Gosalvez, Revvity Signals

David Gosalvez, PhD, Executive Director, Strategy & Informatics Portfolio, Revvity Signals

With two decades of experience in scientific software, David Gosalvez brings a rare combination of technical and domain expertise with broad knowledge across scientific use cases. He is a passionate advocate for improving the efficiency and quality of science via innovative software solutions.

As Head of Product Strategy, David works with scientists and IT across pharma and chemical industry to set the direction of the Revvity Signals Informatics portfolio. He also works with other scientific software vendors to integrate complimentary capabilities into our solutions.

Read more...

As Director of Cheminformatics, he was responsible for the sustained growth of ChemDraw and Spotfire Lead Discovery. Previously, David headed the interdisciplinary Science & Technology team chartered with creating the novel data management technologies that underpinned Revvity Signals platform.

Read Less...

David also served as Executive Director of Application Development at CambridgeSoft where he brought to market the Oracle Chemistry Cartridge and ChemBioOffice Enterprise Suite.

Message Presenter

Who Should Attend?

This webinar will appeal to professionals with the following job titles or those in the following fields:

  • Drug discovery Scientists and researchers
  • Bioinformaticians and Computational Biologists
  • Laboratory Managers and Directors
  • R&D executives in pharmaceutical and biotechnology companies
  • Academic Researchers in life sciences
  • Technology Specialists interested in AI/ML applications in science

What You Will Learn

In this webinar, attendees will learn about:

  • How AI and ML are being practically applied in drug discovery
  • Tools that could potentially streamline research processes
  • The future direction of AI in life sciences and its impact
  • How to enhance scientific workflows with augmented intelligence

Xtalks Partner

Revvity Signals Software

Revvity Signals Software, Inc. is a leading provider of innovative software solutions for the pharmaceutical and biotechnology industries. Revvity Signals Software is a division of Revvity, Inc. a dedicated team of about 11,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the well-being and longevity of people globally. Revvity reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is part of the SAP 500 index. https://revvitysignals.com/.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account